Schizophrenia

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

 Bryan L. Roth, M.D., Ph.D., Foundation Scientific Council Member, received a NARSAD Young Investigator Grant in 1992 for work on serotonin receptors
Dr. Bryan L. Roth
March 21, 2013
Bryan L. Roth, M.D., Ph.D., Foundation Scientific Council Member, received a NARSAD Young Investigator Grant in 1992 to study the structure and function of...
Transcranial Magnetic Stimulation used generally to treat depression, is now being used to treat schizophrenia symptoms
Transcranial Magnetic Stimulation
March 14, 2013
A team of researchers from the University of Toronto, led by Zafiris J. Daskalakis, M.D., Ph.D., FRCP(C), three-time NARSAD Grantee and Associate Professor in...
NARSAD Distinguished Investigator Grantee, Martin Schalling, M.D., Ph.D., Karolinska Institutet in Sweden, Expert on Schizophrenia and Bipolar Disorder Research
Martin Schalling, M.D., Ph.D.
March 12, 2013
NARSAD Distinguished Investigator Grantee, Martin Schalling, M.D., Ph.D. was among a team of researchers from the Karolinska Institutet in Sweden who recently...
NARSAD Grantee, Aristotle Voineskos, M.D., Ph.D., FRCP(C) from the Centre for Addiction and Mental Health (CAMH), Expert on Schizophrenia
Dr. Aristotle Voineskos
March 06, 2013
In a new imaging-genetics study, NARSAD Grantees have uncovered a single gene that may explain dramatic differences among people with schizophrenia. The study...
Tiffany Herlands, Psy.D.
Tiffany Herlands, Psy.D.
March 01, 2013
WOMEN’S MENTAL HEALTH CONFERENCE: THE ART & SCIENCE OF CARINGOn September 14, 2012 the Brain & Behavior Research Foundation hosted a Women’s Mental...

Pages

Subscribe to